Results 251 to 260 of about 108,460,457 (303)

Sensitive and Rapid Dual One-Tube Recombinase Aided PCR Assays for the Simultaneous Detection of Cytomegalovirus, Epstein-Barr Virus, Human Herpesvirus 6, and Herpes Simplex Virus 1/2 in Whole Blood From Children Undergoing Hematopoietic Stem Cell Transplantation. [PDF]

J Med Virol
Zhao L, Zhao M, Gao Y, Tie Y, Guo Y, Zhang S, Wang Y, Ma D, Shao Z, Feng Z.   +9 more
europepmc   +1 more source

Validation of human sensory neurons derived from inducible pluripotent stem cells as a model for latent infection and reactivation by herpes simplex virus 1. [PDF]

mBio
Oh HS, Chou S-F, Raja P, Shim J, Das B, Pesola JM, Romero N, Lee JS, Ng A, Buttermore ED, Church G, Woolf CJ, Coen DM, Knipe DM.   +13 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Herpes Simplex Virus Type 1 Pneumonia—A Review

Journal of Intensive Care Medicine, 2021
Background: Pneumonia due to herpes simplex virus (HSV) is uncommon but can be seen in immunocompromised patients and has been associated with poor prognosis in this population. Aim: The aim was to study the results, outcome and ...
Marlene Ersgaard Jellinge, Frank Hansen, John Eugenio Coia, Zhijun Song   +3 more
openaire   +3 more sources

Oncotarget Strategies For Herpes Simplex Virus-1

Current Gene Therapy, 2016
The high level of manipulability of viral genome has set up HSV-1 to be an ideal viral vector for oncolytic virotherapy. In the past two decades, several oncolytic HSV-1 viruses have been successfully developed and assessed in animal studies. Accumulated evidences show that oncolytic HSV- 1 can efficiently infect many tumor cells and augment anti-tumor
Lumin, Zhang, Tsurumi, Tatsuya, Yukihiro, Nishiyama   +2 more
openaire   +2 more sources

Hemagglutination by herpes simplex virus type 1

Archives of Virology, 1990
The McIntyre and HSZP strains as well as clinical isolate of herpes simplex virus type 1 were found to agglutinate C57Bl/10su and CBA mouse red blood cells. The hemagglutinating activity was inhibited by antisera that neutralized the infectivity of the virus.
E, Trybała, Z, Larski, J, Wiśniewski
openaire   +2 more sources

A Novel Anti-Herpes Simplex Virus Type 1-Specific Herpes Simplex Virus Type 1 Recombinant

Human Gene Therapy, 1999
A recombinant herpes simplex virus (HSV) capable of inhibiting its own replication as well as the replication of wild-type virus would have greatly increased safety as a general purpose vector for in vivo gene transfer, antitumor therapy, and viral vaccine against HSV infection.
F, Yao, E, Eriksson
openaire   +2 more sources

The Role of Herpes Simplex Virus-1 and Herpes Simplex Virus-2 in Atherosclerosis

2013
In this chapter, we discuss a relationship between herpes simplex virus (HSV) and atherosclerosis. According to the current reports, there are several pathways which may lead to the development of HSV-driven atherogenesis. Among these pathways are alteration of lipid metabolism, prothrombic activity, and expression of lectin-like oxLDL receptor (LOX-1).
Anton Kutikhin, Elena Brusina, Arseniy E. Yuzhalin   +2 more
openaire   +1 more source

Ribonucleotide reductase of herpes simplex virus type 2 resembles that of herpes simplex virus type 1

Journal of Virology, 1984
The ribonucleotide reductase (ribonucleoside-diphosphate reductase; EC 1.17.4.1) induced by herpes simplex virus type 2 infection of serum-starved BHK-21 cells was purified to provide a preparation practically free of both eucaryotic ribonucleotide reductase and contaminating enzymes that could significantly deplete the substrates.
D R, Averett, P A, Furman, T, Spector
openaire   +2 more sources